# Bancorp 34, Inc.: overview BCTF · OTC · CIK 1668340 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bctf.md) · [Financials](/companies/bctf/financials.md) · [Filings](/companies/bctf/filings.md) · [Insiders](/companies/bctf/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.11](/filings/0001552781-24-000342.md) | [0.01](/filings/0001552781-24-000486.md) | [(0.52)](/filings/0001552781-24-000598.md) | not reported | [(0.31)](/filings/0001552781-24-000342.md) | [0.21](/filings/0001552781-24-000486.md) | [0.22](/filings/0001552781-24-000598.md) | not reported | | Free cash flow | $k | [721](/filings/0001552781-24-000342.md) | [1,442 d](/filings/0001552781-24-000486.md) | [2,041 d](/filings/0001552781-24-000598.md) | [(3,520) d](/filings/0001552781-25-000058.md) | [(1,344)](/filings/0001552781-24-000342.md) | [1,282 d](/filings/0001552781-24-000486.md) | [2,168 d](/filings/0001552781-24-000598.md) | [368 d](/filings/0001552781-25-000058.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.33](/filings/0001437749-20-002924.md) | [0.23](/filings/0001437749-20-002924.md) | [0.56](/filings/0001552781-24-000084.md) | [(0.88)](/filings/0001552781-25-000058.md) | [0.25](/filings/0001552781-25-000058.md) | | Free cash flow | $m | [(7.4)](/filings/0001437749-20-002924.md) | [32.0](/filings/0001437749-20-002924.md) | [9.1](/filings/0001552781-24-000084.md) | [0.7](/filings/0001552781-25-000058.md) | [2.5](/filings/0001552781-25-000058.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bctf/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Siena Capital Partners GP, LLC](/funds/1694886.md) | 2026-06-30 | $1.6m | 107,142 | | Unchanged | | [BANC FUNDS CO LLC](/funds/1029311.md) | 2026-06-30 | $951.7k | 61,857 | | Reduced −45,000 | ## Recent filings [All 176 filings](/companies/bctf/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2025-03-06 | 16:31 ET | [10-K](/filings/0001552781-25-000058.md) | Annual report, period 2024-12-31 | 0001552781-25-000058 | | 2024-11-20 | 17:38 ET | [8-K](/filings/0001552781-24-000610.md) | 5.07 Shareholder vote results | 0001552781-24-000610 | | 2024-11-13 | 16:31 ET | [10-Q](/filings/0001552781-24-000598.md) | Quarterly report, period 2024-09-30 | 0001552781-24-000598 | | 2024-08-14 | 15:10 ET | [10-Q](/filings/0001552781-24-000486.md) | Quarterly report, period 2024-06-30 | 0001552781-24-000486 | | 2024-05-31 | 16:05 ET | [8-K/A](/filings/0001552781-24-000372.md) | 9.01 Financial statements and exhibits | 0001552781-24-000372 | | 2024-05-15 | 12:56 ET | [10-Q](/filings/0001552781-24-000342.md) | Quarterly report, period 2024-03-31 | 0001552781-24-000342 | | 2024-04-24 | 16:06 ET | [8-K](/filings/0001552781-24-000246.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001552781-24-000246 | | 2024-04-05 | 16:05 ET | [8-K](/filings/0001552781-24-000218.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001552781-24-000218 | | 2024-03-21 | 13:40 ET | [8-K](/filings/0001552781-24-000167.md) | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001552781-24-000167 | | 2024-03-11 | 17:50 ET | [8-K](/filings/0001552781-24-000093.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001552781-24-000093 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2024](/filings/0001552781-25-000058.md), filed Mar 6, 2025. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1668340 - Tickers: BCTF - Exchange: OTC - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: MD - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.